XML 62 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Roll Forward of Stock Options
The following table summarizes the status of, and changes in, our stock options during 2021.
OptionsWeighted-
average
exercise
price
Weighted-average
remaining
contractual
term in
years
Outstanding at December 31, 20204,379,663 $71.67 
Exercised(1,533,084)$69.44 
Outstanding at December 31, 20212,846,579 $72.87 2.5
Exercisable at December 31, 20212,846,579 $72.87 2.5
Schedule of Roll Forward of Nonvested Restricted Shares and Restricted Stock Units
The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during 2021. 
Restricted
shares
Restricted
stock
units
Weighted-
average
fair value
Nonvested at December 31, 20207,412 6,367,059 $116.51 
Time-based grants5,720 1,596,036 $203.87 
Performance-based grants— 66,845 $204.22 
Vested (value at vest date was $426.6 million)
(7,412)(2,154,853)$104.05 
Nonvested dividend equivalents granted to non-employee directors— 3,515 $193.49 
Forfeited— (176,737)$117.24 
Nonvested at December 31, 20215,720 5,701,865 $146.87 
Schedule of Future Stock-based Compensation Expense
The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at December 31, 2021. Estimated future compensation expense will change to reflect future grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.
(in millions)
First quarter 2022$67.4 
Second quarter 202264.6 
Third quarter 202263.7 
Fourth quarter 202254.9 
Total 2022250.6 
2023 through 2027232.6 
Total$483.2